Nevertheless, given the large numbers of pregnant women identified as being affected by hookworm, and at risk of hookworm-related anaemia therefore, which is treatable easily, further research are warranted, and initiatives should be made to increase coverage of anthelmintic treatment among women that are pregnant in sub-Saharan Africa’.. 7 million women that are pregnant in sub-Saharan Africa infected with hookworms A report published by PLoS reveals that between a quarter and a third of pregnant women in sub-Saharan Africa, or almost 7 million, are infected with hookworms, putting them at risk of anaemia.The trial methods have already been described previously.16 The protocol was approved by the local analysis ethics committee in Liverpool, UK, and by the regional ethical review table in Uppsala, Sweden. Oversight was supplied by a basic safety and data monitoring panel. Data were collected by the investigators and had been analyzed by a statistician , who vouches for the accuracy and completeness of the info reported. All the authors attest to adherence of the study to the protocol. LGC offered the point-of-care genotyping assay with funding from the European Union. Trial Participants We recruited individuals in britain and Sweden . Eligible patients hadn’t received prior treatment with warfarin and experienced either atrial fibrillation or venous thromboembolism that was deemed by their attending doctor to need anticoagulation with warfarin with a target INR of 2.0 to 3.0.